METHOD AI develops an image-guided surgical navigation platform that provides physicians with continuous deep tissue imaging and real-time guidance during robotic procedures. This technology addresses the incomplete visualization faced by surgeons, particularly in oncology, by integrating AI-generated surgical plans. The platform aims to enhance the precision of robotic surgery, leading to improved patient outcomes by ensuring complete resection of the surgical target.
Funding
Funding not disclosed
Founders
Product
Problem
Robotic surgical oncology procedures often suffer from incomplete visualization of the surgical target, leading to residual cancer, unforeseen complications, and potential loss of organ function. Surgeons using robotic endoscopes face the challenge of limited visibility within deep tissue.
Solution
Method AI is developing an image-guided surgical navigation platform designed to enhance the precision of robotic surgical systems. The platform provides surgeons with continuous deep tissue imaging and real-time guidance, leveraging AI-generated surgical plans. By offering improved visualization and data, the technology aims to minimize the risk of leaving cancer behind and reduce the occurrence of complications during robotic oncology procedures. This enhanced guidance seeks to improve surgical outcomes and preserve organ function for oncology patients.
Target Audience
The primary target audience includes surgical oncologists and hospitals utilizing robotic surgical systems for cancer treatment.
Features
- AI-driven surgical planning for optimized resection strategies.
- Continuous deep tissue imaging to enhance visualization during procedures.
- Real-time surgical guidance overlaid on the surgical field.
- Integration with existing robotic surgical systems.